The following information is missing from the Funding section: Work by IR and co-workers is primarily supported by Wellcome Trust Infrastructure Support Fund of the University of Manchester and the European Research Council.
There is an error in the Acknowledgments section. This section should read: We thank Jacobus Pharmaceutical Company, Princeton, NJ for the kind provision of WR99210 and ATCC (MR4) for BiP antibody, D. Taylor for HRPII antibody, L. Romani and A. Vecchiarelli for fluorimeter access; and B. Sleebs and J. Boddey for WEHI916.
Citation: Gambini L, Rizzi L, Pedretti A, Taglialatela-Scafati O, Carucci M, Pancotti A, et al. (2016) Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. PLoS ONE 11(1): e0146627. https://doi.org/10.1371/journal.pone.0146627
Published: January 4, 2016
Copyright: © 2016 Gambini et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited